| 1 |
18421578 | Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. | 2008 Jun |
7 |
| 2 |
15634660 | Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death. | 2004 Dec |
2 |
| 3 |
12823542 | Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703. | 2003 Jul |
1 |
| 4 |
12838325 | Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. | 2003 Jul 7 |
1 |
| 5 |
14500373 | Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. | 2003 Sep 1 |
2 |
| 6 |
12014636 | Chemosensitization of T-47D breast carcinoma cells to TRAIL and Fas receptor-induced killing. | 2002 Mar-Apr |
1 |
| 7 |
10594023 | Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. | 2000 Jan |
7 |
| 8 |
11090076 | Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. | 2000 Dec 1 |
1 |